Cell Press, The Lancet & Societies Publishing

As a researcher, you want to learn techniques and strategies to set yourself up for publishing success. On our premium content channel, you can find useful resources to learn the best practices on preparing manuscripts for publication and discovering the best journal for your research. Join esteemed editors from premium journals like Cell Press, The Lancet and Societies publishing to learn tips on publishing in top journals. Browse through our extensive catalogue to uncover a world of knowledge, explore practical advise and resources to publish in highly selective titles, and earn certificates and rewards as your progress on your learning.

The Lancet

The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.

Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world.

The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives.

In this section, you can expect to uncover useful and practical resources from Lancet editors to apply to your strategies for publishing success as well as your knowledge of pressing issues within clinical medicine and global health.

Total Time
16+ hours
Complete
0 / 14
Language
  • English
  • Chinese

What you will learn

  • Content and Manuscript Writing Tips
  • Guidance on publishing with top journals
  • How to set yourself up for publishing success
14 modules
1.2 h
The Lancet

Best practices for submitting to Lancet journals and open access options

Do you want advice on how to prepare your manuscripts for publication in the best open access journals for your research?
1 h
The Lancet

COVID-19 Vaccines: An Update on Research & Global Availability

Join John McConnell, Editor-in-Chief of The Lancet Infectious Diseases to update yourself on the latest scientific viewpoints regarding the workings of the COVID-19 vaccines.
1.2 h
The Lancet

Learn how Lancet editors decide which papers to accept for publication

Join Heather Van Epps, Editor-in-Chief of The Lancet Rheumatology, to learn about techniques and strategies for preparing your paper to submit to high-impact journals.
1.2 h
The Lancet

Improving diversity and inclusion in research and publishing

Gender equity is not only a matter of justice and rights, it is crucial for producing the best research and providing the best care to patients.
1.2 h
The Lancet

Learn valuable tips from a Lancet Editor!

Are you wondering how editors make decisions to accept a paper for publication? Are you struggling with which type of information to include in the methods section?
43 m
The Lancet

Techniques and strategies for submission to The Lancet

Join Dr Diana Stanley, Deputy Editor of The Lancet Respiratory Medicine, to learn about:   • The Lancet family of journals’ peer review process
1.3 h
The Lancet

Authoring in The Lancet — Learn from the Editors!

Join John McConnell, Editor-in-Chief of The Lancet Infectious Diseases to learn about techniques and strategies for authoring in high-impact journals.
59 m
The Lancet

爱思唯尔卓越科研在线讲座:在《柳叶刀》上发表论文——专为中国研究人员打造的中文在线讲座!

与《柳叶刀》亚洲区执行主编王辉(Helena Wang)女士一起学习在高影响力期刊上发表论文的技巧和策略。王辉女士将分享她在整个研究论文发表周期中与研究人员和论文作者合作的经验,介绍如何撰写能够在优质出版物上发表的论文,以及广泛传播研究成果的机会。本次在线研讨会内容精彩纷呈,不容错过,能够让您的研究过程和研究影响再上新台阶。
19 m
The Lancet

The Lancet Group - the best science to help you improve lives

Please note: the first part of this webinar, Dr. Ceschia’s presentation, was not recorded.
1 h
The Lancet

Modernising haematological malignancy adverse event assessment and reporting

Remarkable improvements in outcomes for many haematological malignancies have been driven primarily by a proliferation of novel therapeutics over the past two decades.
1 h
The Lancet

Urban design, transport, and health

We are pleased to invite you to the global launch of the Lancet Global Health Series on urban design, transport, and health.
2 h
The Lancet

Sustainable care for children with cancer: a Lancet Oncology Commission

Cancer kills more than 100,000 children each year, and yet 80% of paediatric cancers are curable with currently available interventions.
2 h
The Lancet

Emerging technologies and clinical research in Latin America

Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries.
1 h
The Lancet

HIV-related haematological malignancies: a joint Series from The Lancet Haematology and The Lancet HIV

Join Peter Hayward, Editor-in-Chief of The Lancet HIV, and the Series authors as they introduce and explore the findings from this new joint Series on HIV-related haematological malignancies from The Lancet Haematology and The Lancet HIV.